ArticleTrials2026
Mixed-methods process evaluation of the "Karl-Heinz" cardiac prehabilitation program in older patients: protocol for the PRECOVERY trial.
Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundStructured cardiac prehabilitation programs for older patients prior to cardiac procedures address an unmet medical need, yet implementation evidence remains scarce. "Karl-Heinz" (Kognitiv & kardiale Prehabilitation vor Herzinterventionen; cognitive and cardiac prehabilitation prior to cardiac procedures) is a tailored prehabilitation program designed to improve quality of life and reduce mortality 12 months after elective cardiac procedures. PRECOVERY is a randomized, controlled, two-arm parallel group, assessor-blinded, multicenter trial evaluating its clinical efficacy. This study protocol outlines the embedded mixed-methods process evaluation examining both the delivery and implementation of "Karl-Heinz." The objectives are (1) to examine the implementation process across prehabilitation centers, including contextual barriers and facilitators; (2) to assess the intervention's fidelity, dose, adaptations, reach, and the quality of health professional training; and (3) to analyze key stakeholders' perspectives on implementation and perceived impact.
methodsThe quantitative strand will collect standardized questionnaires from trial participants (n = 422, aged ≥ 65 years), their relatives, and health professionals from participating prehabilitation centers. Additional data sources include therapy plans and patient diaries. Furthermore, we will systematically analyze evaluation data from health professionals delivering the intervention to assess training delivery. The data will be analyzed using the "joint frailty model for longitudinal data and terminal event", supplemented by exploratory analyses of main trial data. The qualitative strand will include semi-structured interviews with a subsample of patients (n = 24) and relatives (n = 24) before and after the cardiac procedure. We will interview physicians performing the cardiac procedure (n = 9) and conduct focus groups (three with health professionals involved in prehabilitation delivery, two with general practitioners of prehabilitated patients). Qualitative data will be analyzed using structured qualitative content analysis. The results from both strands will be triangulated and related to the results from the main trial. DISCUSSION: This process evaluation will provide detailed insights into the implementation and perceived impact of "Karl-Heinz." Capturing perspectives from multiple stakeholder groups along with a detailed analysis of training processes will help to identify contextual factors, facilitators, barriers, and deviations. The mixed-methods approach will enable a thorough understanding, support the intervention's refinement, optimize allocation of resources, overall reproducibility, and the assessment of possible integration into routine care.
trial registrationGerman Clinical Trials Register (DRKS; http://www.drks.de ; DRKS00030526). Registered on 30 January 2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.